GLP-1 statistics 2026: trial results, use and cost in numbers
GLP-1 statistics from trial papers, FDA labels, CDC and KFF: weight loss, side effects, stopping, regain, use and costs. Updated November 10, 2026.
Statistics
3 source-based articles maintained by the HealthRX.com Editorial Team.
3articles
3topic areas covered
Nov 10, 2026latest review
Statistics library
Showing 3 of 3 clinical reviews.
Hair loss statistics 2026: prevalence and treatment results
Hair loss figures from published trials and FDA labels: how common it is by age and sex, and what finasteride, minoxidil and JAK inhibitors did.
Peptide statistics 2026: what the human studies actually show
A plain count of the human evidence on BPC-157, ipamorelin, tesamorelin, CJC-1295, KPV and Semax, from papers, FDA documents and trial registries.